Strategies to Increase HMG-CoA Reductase Inhibitor Use After Acute Myocardial Infarction

Author： Joseph B. Muhlestein  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.9, 2004-01, pp. : 583-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction

By Riahi S.   Hagstrup Christensen J.   Toft E.   Aarup Skou H.   Berg Schmidt E.  

Pharmacological Research, Vol. 45, Iss. 6, 2002-06 ,pp. : 479-483

Academic Press

Access to resources Recommend Favorite

Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

By Maroo Bijesh P.   Lavie Carl J.   Milani Richard V.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 649-664

Adis International

Access to resources Recommend Favorite

Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy

By Rosenson R.S.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

NK-104: a novel synthetic HMG-CoA reductase inhibitor

By Kajinami K.   Mabuchi H.   Saito Y.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2653-2661

Informa Healthcare

Access to resources Recommend Favorite

HMG CoA reductase inhibitor therapy underused after CAGB

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 364, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite